tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CMVLF Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
12d ago
ALT
CLLS
Cellectis Reports 2024 Financial Results and Strategic Progress
PremiumCompany Announcements
Cellectis Reports 2024 Financial Results and Strategic Progress
14d ago
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
PremiumRatings
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
15d ago
CLLS
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
PremiumCompany Announcements
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
15d ago
Cellectis Advances Clinical Programs and Strengthens AstraZeneca Partnership
PremiumCompany Announcements
Cellectis Advances Clinical Programs and Strengthens AstraZeneca Partnership
15d ago
Cellectis reports Q4 EPS (64c) vs (17c) last year
PremiumThe FlyCellectis reports Q4 EPS (64c) vs (17c) last year
15d ago
AZN
CLLS
Cellectis files to sell 44M ordinary shares for holders
Premium
The Fly
Cellectis files to sell 44M ordinary shares for holders
2M ago
CLLS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BLRX
CLLS
Cellectis SA: Financial Growth Amidst Strategic Partnerships
PremiumCompany Announcements
Cellectis SA: Financial Growth Amidst Strategic Partnerships
5M ago
Cellectis price target lowered to $5 from $7 at Barclays
PremiumThe Fly
Cellectis price target lowered to $5 from $7 at Barclays
5M ago
CLLS
Cellectis reports Q3 EPS (22c), consensus (21c)
PremiumThe Fly
Cellectis reports Q3 EPS (22c), consensus (21c)
5M ago
CLLS
CMVLF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CMVLF Earnings this Week: How Will it Perform?
5M ago
Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
PremiumThe FlyCellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
7M ago
CLLS
Cellectis granted orphan drug designation for CLLS52
Premium
The Fly
Cellectis granted orphan drug designation for CLLS52
8M ago
CLLS
FDA grants Cellectis’ UCART22 ODD and RPDD status for ALL treatment
Premium
The Fly
FDA grants Cellectis’ UCART22 ODD and RPDD status for ALL treatment
8M ago
CLLS
Cellectis treatment of acute lymphoblastic leukemia granted orphan designation
PremiumThe Fly
Cellectis treatment of acute lymphoblastic leukemia granted orphan designation
8M ago
CLLS
Cellectis publishes approach for sickle cell disease in Nature Communications
PremiumThe Fly
Cellectis publishes approach for sickle cell disease in Nature Communications
10M ago
CLLS
Cellectis price target lowered to $10 from $11 at Oppenheimer
PremiumThe Fly
Cellectis price target lowered to $10 from $11 at Oppenheimer
10M ago
CLLS
Cellectis aanounces EG granted ODD to product candidate UCART22
PremiumThe Fly
Cellectis aanounces EG granted ODD to product candidate UCART22
10M ago
CLLS
Cellectis reports Q1 EPS 0c, consensus (33c)
PremiumThe FlyCellectis reports Q1 EPS 0c, consensus (33c)
10M ago
CLLS
Cellectis announces completion of $140M investment from AstraZeneca
Premium
The Fly
Cellectis announces completion of $140M investment from AstraZeneca
11M ago
AZN
CLLS
Cellectis appoints Arthur Stril as interim CFO
Premium
The Fly
Cellectis appoints Arthur Stril as interim CFO
11M ago
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >